BioDuro-Sundia Appoints Dr. Armin Spura as New CEO

Share This Post

Key Highlights

  • Dr. Armin Spura appointed as BioDuro-Sundia’s new CEO
  • Brings over two decades of experience in life sciences and biotechnology
  • Led Crown Bioscience as CEO for five years
  • Previously held leadership roles at Thermo Fisher Scientific, WuXi NEXTCODE, CareDx, and Ion Torrent
  • BioDuro-Sundia offers fully integrated CRDMO services from discovery to commercial manufacturing

Source: Business Wire

Notable Quotes

  • “With our unique, fully integrated CRDMO platform — encompassing chemistry, biology, DMPK, drug substance, and drug product from discovery through to commercial manufacturing — I am confident we will empower more partners to bring better treatments to patients around the world faster.” — Dr. Armin Spura, CEO at BioDuro-Sundia
  • “Dr. Spura’s extensive global experience and visionary leadership is instrumental in driving BioDuro-Sundia’s accelerated growth.” — Gary Chu, Chairman of the Executive Operation Committee at BioDuro-Sundia

SoHC's Take

The appointment of Dr. Armin Spura as CEO marks a strategic move for BioDuro-Sundia. With his proven track record in scaling companies and fostering innovation, particularly through his leadership at Crown Bioscience, BioDuro-Sundia is poised to accelerate its growth in the CRDMO sector. As the company strengthens its global presence, Spura’s leadership will likely play a pivotal role in expanding their integrated solutions and addressing the evolving needs of the life sciences industry. This leadership change could further enhance BioDuro-Sundia’s position as a leading CRDMO in the global market.

Heading

Key Highlights CalmWave closes a $5.25M financing round led by Third Prime with contributions from Catalyst by Wellstar, Silver Circle, and ...
/
Key Highlights Alice Koehler appointed Managing Director of OMRON Healthcare North America. Koehler brings 25+ years of global experience in ...
/
Key Highlights Koda Health introduces Kidney Action Planning to support Chronic Kidney Disease (CKD) management with cutting-edge tools. Features include gamified patient ...
/
Key Highlights Northwell Health’s Aging Revolution Summit will take place virtually and in-person in NYC on December 3, 2024. Key themes: Therapeutics, ...
/
Key Highlights $5M Series A funding led by Empactful Capital to fuel growth and innovation. Investment will support product development, strategic accounts, and new market ...
/
Key Highlights New Lantern raises $19M Series A funding, led by Benchmark, totaling $23M raised to date. Platform automates 25% of ...
/

More To Explore

Total
0
Share